Not yet recruiting
Central nervous system neoplasm
Not yet recruitingSafety of autologous NK cells with IL‑15 and CD45RA‑negative T cells with NKG2D CAR in children, adolescents and young adults with high‑grade brain tumors
InvestigationalNo placebo
Safety of autologous NK cells with IL‑15 and CD45RA‑negative T cells with NKG2D CAR in children, adolescents and young adults with high‑grade brain tumors
InvestigationalNo placebo
- Disease:Central nervous system neoplasm
- Substances:AUTOLOGOUS PERIPHERAL BLOOD-DERIVED CD45RA- T-CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR ENCODING A CHIMERIC ANTIGEN RECEPTOR AGAINST NKG2-D TYPE II INTEGRAL MEMBRANE PROTEINAUTOLOGOUS PERIPHERAL BLOOD-DERIVED NK CELLS STIMULATED EX-VIVO WITH INTERLEUKIN-15
Countries:
Spain
Spain- Participants:0–17 years · 18–64 years
- Substances:AUTOLOGOUS PERIPHERAL BLOOD-DERIVED CD45RA- T-CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR ENCODING A CHIMERIC ANTIGEN RECEPTOR AGAINST NKG2-D TYPE II INTEGRAL MEMBRANE PROTEIN